Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
If you want tighter expense control and explicit assignment of funds, zero based budgeting can be worth trying. This intro explains potential gains and a simple starting point.
26,943 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Brera stock is in sharp focus as the company leans into a crypto-first strategy connected to Solana. The move has spa...
Dell Technologies stock just moved on headlines about a rival's legal trouble, but the bigger question for investors ...
New York Fed researchers find a widening gap in how households respond to rising gas prices after the Iran-related sh...
Get a clear, real-world view of Ligand (LGND) 2026 earnings. This guide breaks down revenue sources, milestones, and ...
Nokia stock jumped today as investors cheered a fresh AI-driven approach to network management. The move hints at a b...
A sudden drop in Navitas stock sent ripples through growth-focused portfolios. This guide explains the key drivers, w...
A stock delivering a 7% dividend yield and yet slipping 20% year-to-date may seem puzzling. This guide explains how t...
Global markets can offer growth outside the U.S. In this guide, we break down why international stocks may outperform...
How do two AI infrastructure players compare when it comes to revenue scale? This article breaks down the factors, me...
Quantum computing could reshape many industries, but is IonQ stock your ticket to millionaire status? This guide expl...
Markets often misread good news when it signals a larger shift. This piece explores how talks, strategic reserves, an...